81 Results for "

GPC3 knockdown

" in MedChemExpress (MCE) Product Catalog:
Products (81)

81 Results for "GPC3 knockdown" in MCE Product Catalog:

4
4 Cited Publications
Cat. No.: HY-B0827
CAS No.: 165252-70-0
Synonyms: MTI-446
Dinotefuran is an orally active and competitive inhibitor and insecticide targeting insect nicotinic acetylcholine receptors (nAChRs). Dinotefuran blocks neural signaling and induces neural dysfunction in insects. Dinotefuran binds to [ 3H]epibatidine in the neural cord membrane of American cockroach with an IC50 of 890 nM and to [ 3H]α-bungarotoxin with an IC50 of 36.1 μM. Dinotefuran exhibits knockdown activity (KD50=0.351 nmol/g) and lethal activity (LD50=0.173 nmol/g) against German cockroach. Dinotefuran is mainly used for agricultural pest control, such as field control of piercing-sucking and chewing insects (e.g., aphids, planthoppers), while its environmental toxicological effects (e.g., oxidative stress and reproductive neurotoxicity on earthworms) are also a research focus to assess ecological risks [3].
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P99013
CAS No.: 1365267-33-9
Synonyms: GC33; RO5137382
Target:  

Glycoprotein VI

Research Areas:  

Cancer

Codrituzumab (GC33) is a humanized monoclonal antibody targeting human GPC3 (glypican-3), with high affinity (Kd of 0.673 nM). GPC3 is an oncofetal protein expressed on the cell surface of hepatocellular carcinoma (HCC). Codrituzumab induces antibody-dependent cellular cytotoxicity (ADCC) and inhibits tumor growth [3] .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-161719
CAS No.: 3083634-54-9
Target:  

β-catenin Ferroptosis

Research Areas:  

Cancer

NF764 is a CTNNB1 degrader. When used in combination with USP38 knockdown, NF764 exhibits synergistic anti-tumor activity and induces Ferroptosis. NF764 can be used in studies related to colorectal cancer and melanoma .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-161766
CAS No.: 2776151-36-9
Research Areas:  

Cancer

L687 is an activator of TRPC3, TRPC6, and TRPC7 cation channels and induces calcium influx. L687 induces macropinocytosis and endocytosis. L687 enhances cellular uptake and knockdown activity of antisense oligonucleotides. L687 alone does not alter SRRM4 expression. L687 can be used for research on small cell lung cancer .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P70487
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: GPC3; SGB; Prev. SDYS; Glypican Proteoglycan 3; Glypican-3; GTR2-2; OCI-5; MXR7; SGBS1; Heparan Sulphate Proteoglycan; SGBS; Secreted Glypican-3; DGSX; OCI5; Glypican 3; Intestinal Protein OCI-5
Species:  
Human
Source:  
HEK293
loading...
    loading...
Cat. No.: HY-153360
CAS No.: 2873460-70-7
Purity:  98.99%
Research Areas:  

Cancer

MC-GGFG-AM-(10Me-11F-Camptothecin) is a linker-payload conjugate used to synthesize ZW251. ZW251 an antibody-drug conjugate (ADC) targeting human GPC3. ZW251 consists of a humanized IgG1 antibody conjugated to a novel camptothecin-based topoisomerase 1 inhibitor, ZD06519, via a linker. The linker is the maleimide anchor and a glycyl glycyl phenylalanyl glycine (GGFG)-aminomethyl (AM) cleavable linker. ZW251 has high affinity with human and cynomolgus monkey GPC3. ZW251 displays rapid internalization in GPC3-expressing HCC cell lines, and bystander-mediated killing of GPC3 negative cancer cells .
loading...
    loading...
Cat. No.: HY-W1124925
CAS No.: 3066439-94-6
DOTA-GPC3 targeting peptide 2 (Sequence 30) is a RDC peptide targeting GPC3, with Kd of 0.3 nM. DOTA-GPC3 targeting peptide 2 is composed of DOTA and GPC3 targeting peptide 2. DOTA-GPC3 targeting peptide 2 can be labeled with radioactive elements .
loading...
    loading...
Cat. No.: HY-P5423
CAS No.: 107658-43-5
Target:  

Exosomes Liposome

Research Areas:  

Cancer

GALA is a pH-responsive amphipathic peptide consisting of 30 amino acids, which acts as a lung endothelium-targeting ligand. GALA undergoes a conformational transition from random coil to α-helix in an acidic environment at pH 5.0, thereby inducing endosomal membrane destabilization and fusion. GALA-modified liposomes traverse lung endothelial cells via clathrin-dependent endocytosis and transcytosis, and specifically accumulate in the lungs after intravenous injection. GALA significantly promotes the cytosolic release of cargos carried by exosomes, plasmids and liposomes, effectively enhances gene transfection efficiency, and drives gene knockdown of functional macromolecules (such as siRNA) in alveolar epithelial cells (with no significant cytotoxicity at effective concentrations). GALA serves as a critical tool for studies on lung cancer metastasis (e.g., melanoma lung metastasis) and lung-targeted drug delivery systems [3].
loading...
    loading...
Cat. No.: HY-P10888A
Target:  

Glycoprotein VI

Research Areas:  

Cancer

GPC3 targeting peptide 1 TFA is a GPC3 targeting peptide, with a Kd value of 0.23 nM .
loading...
    loading...
Cat. No.: HY-W587427
CAS No.: 70195-25-4
D-2-Phosphoglyceric acid trisodium is a glycolysis and gluconeogenesis intermediate with altered levels linked to MCT4-modulated glycolytic pathways. D-2-Phosphoglyceric acid trisodium shows reduced intracellular levels in hypoxic glioblastoma stem cells after MCT4 knockdown. D-2-Phosphoglyceric acid trisodium can be used for the research of glioblastoma .
loading...
    loading...
Cat. No.: HY-P10888
CAS No.: 3066113-41-2
Target:  

Glycoprotein VI

Research Areas:  

Cancer

GPC3 targeting peptide 1 is a GPC3 targeting peptide, with a Kd value of 0.23 nM .
loading...
    loading...
Cat. No.: HY-P990841

Target:  

Glycoprotein VI

Research Areas:  

Cancer

Anti-pan-Glypican Antibody (HS20) is a kind of human IgG1 κ human antibody, targeting to human pan-Glypican. Anti-pan-Glypican Antibody (HS20) can neutralize the heparan sulfate (HS) chains on GPC3 thereby disrupting the Wnt3a-GPC3 interactions leading to blockade of the Wnt3a/β-catenin signaling. Anti-pan-Glypican Antibody (HS20) can be used for the research of cancer, such as hepatocellular carcinoma (HCC) .
loading...
    loading...
Cat. No.: HY-145939
CAS No.: 2468783-75-5
Purity:  98.27%
Synonyms: BRD5846
Target:  

Casein Kinase

Research Areas:  

Cancer

BAY-888 is a selective CK1α/CSNK1A1 (casein kinase 1α) ATP-competitive inhibitor (IC50: 4 nM@10 μM ATP; 63 nM@1 mM ATP). BAY-888 blocks the negative regulation of p53 and other signaling pathways by CK1α, induces apoptosis and inhibits proliferation of tumor cells. BAY-888 has shown inhibitory efficacy against cancers such as acute myeloid leukemia (AML) in PRISM barcoded cell line screening and can mimic the effects of shRNA-mediated CK1α knockdown. BAY-888 is primarily used for the development of anticancer drugs for p53 wild-type tumors and for the study of the mechanisms of CK1α-related signaling pathways [3].
loading...
    loading...
Cat. No.: HY-P990840

Target:  

Glycoprotein VI

Research Areas:  

Cancer

Anti-GPC3 Antibody (YP7) is a kind of mouse IgG1 κ chimeric antibody, targeting to human GPC3. Anti-GPC3 Antibody (YP7) reacts with the C-lobe of cell surface-associated glypican-3 (GPC3). Anti-GPC3 Antibody (YP7) can be used for the research of cancer, such as hepatocellular carcinoma (HCC) .
loading...
    loading...
Cat. No.: HY-113534
CAS No.: 1001600-54-9
Purity:  98.65%
Target:  

IAP Apoptosis

Research Areas:  

Cancer

MV1 is an antagonist of IAP (inhibitor of apoptosis protein), leads to protein knockdown of HaloTag-fused proteins when combined with HaloTag ligand .
loading...
    loading...
Cat. No.: HY-159692
CAS No.: 2603457-08-3
Synonyms: IONIS-1063734
Target:  

FOXP

Research Areas:  

Cancer

AZD8701 (IONIS-1063734) is an antisense oligonucleotide targeting FOXP3 in regulatory T cells (Tregs), with a human IC50 of 65.2 nM. AZD8701 binds to intronic sites of all FOXP3 pre-mRNA isoforms and mediates dose-dependent FOXP3 knockdown via free uptake. AZD8701 can be used in cancer-related research .
loading...
    loading...
Cat. No.: HY-B0874
CAS No.: 67375-30-8
Synonyms: FMC 45497; Fendona; WL 85871
Research Areas:  

Infection Neurological Disease

Alpha-Cypermethrin (FMC 45497; Fendona; WL 85871) is a type II pyrethroid insecticide. Alpha-Cypermethrin acts by delaying the inactivation of voltage-gated sodium channels, prolonging sodium tail currents, and triggering repetitive neural discharges. Alpha-Cypermethrin exhibits knockdown and lethal activity against target insects such as Musca domestica and Anopheles culicifacies. Alpha-Cypermethrin induces neurotoxicity in mammals, alters placental and fetal neurodevelopment, and causes acute mortality in fish. Alpha-Cypermethrin can be used in studies related to neurotoxicity, vector-borne diseases, and malaria [3] .
loading...
    loading...
Cat. No.: HY-130256
CAS No.: 2380000-55-3
Purity:  99.37%
β-NF-JQ1 is a BRD2/3/4 PROTAC degrader. β-NF-JQ1 recruits the AhR E3 ligase complex to BRD2, BRD3 and BRD4, induces AhR-BRD interaction, and mediates AhR-dependent degradation through the proximity effect between the target protein and AhR. β-NF-JQ1 acts as an antiproliferative and cytotoxic agent that induces anticancer activity associated with BRD protein knockdown. β-NF-JQ1 can be used for research on breast cancer and neuroblastoma .
loading...
    loading...
Cat. No.: HY-RS05628
Research Areas:  

Others

GPC3 Human Pre-designed siRNA Set A contains three designed siRNAs for GPC3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS16630
Research Areas:  

Others

Gpc3 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Gpc3 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...